Английская Википедия:HEC88473
Материал из Онлайн справочника
HEC88473 is an experimental dual GLP-1 and fibroblast growth factor 21 (FGF21) receptor agonist. It is developed by the Chinese company HEC Pharm for diabetes and non-alcoholic steatohepatitis.[1][2]
References
Шаблон:Gastrointestinal-drug-stub